WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs

A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided.
Go to Source
Author: Catherine Saez

WordPress Video Lightbox
Cerca